We suggest you to use Alkem Laboratories fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Alkem Laboratories is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found thirty-one available fundamental indicators for Alkem Laboratories Limited which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Alkem Laboratories fundamentals including its Total Debt, Market Capitalization and the relationship between EBITDA and Earnings Per Share . Use Alkem Laboratories to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Alkem Laboratories to be traded at 1868.58 in 30 days.
Alkem Laboratories Company Summary
Alkem Laboratories competes with Sun Pharmaceutical, Aurobindo Pharma, Dr Reddys, Dr Reddys, and Divis Laboratories. Alkem Laboratories Limited, a pharmaceutical company, develops, manufactures, and sells pharmaceutical and nutraceutical products in India, the United States, and internationally. The company was founded in 1973 and is headquartered in Mumbai, India. Alkem Laboratories operates under Drug Manufacturers - Specialty Generic classification in India and is traded on National Stock Exchange of India.
Alkem Laboratories Book Value Per Share vs Return On Equity
Alkem Laboratories Limited is rated third in book value per share category among related companies. It is rated below average in return on equity category among related companies reporting about 0.03 of Return On Equity per Book Value Per Share. The ratio of Book Value Per Share to Return On Equity for Alkem Laboratories Limited is roughly 34.54
|Book Value Per Share ( times )|
|Return On Equity ( % )|
Alkem Laboratories Systematic Risk